Cirrhosis Clinical Trial
Official title:
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Hepatic encephalopathy (HE) is a potentially reversible, metabolically caused complication
of acute or chronic liver diseases such as cirrhosis. Due to the diseased liver's inability
to remove toxins such as ammonia, which is produced in the gastrointestinal tract, the
ammonia accumulates in the brain and causes forgetfulness, confusion, disorientation,
concentration and memory problems, changes in mood, decreased alertness and responsiveness,
changes in sleep habits, muscle tremors and stiffness, speech impairments, uncontrollable
movements, agitation.
This study will examine music as a possible external factor that could contribute to
impairment in attention and progressive memory in cirrhotic patients while driving.
Sustaining attention is important for learning and remembering new information, for e.g.
keeping the car within lane and paying attention to cyclists and pedestrians. Prospective
memory is the ability to remember to perform previously intended tasks at the appropriate
time or occasion, for instance remembering the correct exit while driving on the highway.
Impairment in any of these areas may result in serious consequences for patient with
cirrhosis. There is evidence that some subsets of cirrhotic patients have a diminished
ability to drive and significantly more motor vehicle crashes and traffic violations. In
these patients, listening to music while driving may further jeopardize their driving
ability, which in turn may lead to reduced quality of life and increased medical costs (from
motor vehicle accidents).
This is a cross-sectional study designed to determine if there is any effect of listening to
music on attention and prospective memory in patients with cirrhosis. For these purposes,
subjects will be asked to come for one study visit, which will last approximately 2 hours.
During this visit, subjects will undergo a series of screening procedures (consent,
assignment of subject identification number, demographics, medical history, physical
examination, vitals, height, weight, and eligibility assessment). If they are found
eligible, subjects will undergo several neuropsychological assessments to measure any effect
of music on attention and prospective memory. These assessments include including Number
Connection Test (NCT), Digit Symbol Test (DST), Cambridge Prospective Memory Test
(CAMPROMPT) and Inhibitory Control Test (ICT).
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Ambulatory patient with cirrhosis - Able to provide informed consent Exclusion Criteria: - History of alcohol abuse within six months - Active gastrointestinal bleeding - Unable to provide informed consent |
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
United States | NYU Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
New York University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Lure Response Inhibition on Inhibitory Control Test | The ICT will be administered with and without background music during a single visit. | No | |
Secondary | Target Responses on Inhibitory Control Test | The ICT will be administered with and without background music during a single visit. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |